# OnCo record elranatamab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/elranatamab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "elranatamab" ;
  schema:name "Elranatamab"@en ;
  schema:description "Elranatamab is Pfizer's BCMA bispecific, given under the skin every week then every two weeks, for myeloma after four prior lines."@en ;
  schema:url <https://onco.cc/drugs/elranatamab/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Elranatamab> ;
  owl:sameAs <http://www.wikidata.org/entity/Q121549012> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Elranatamab> ;
  onco:status "approved" ;
  onco:modality "Bispecific T-cell engager (BCMA×CD3)" ;
  schema:alternateName "Elrexfio" ;
  onco:approval "US 2023: Relapsed/refractory myeloma after ≥4 lines (accelerated)" ;
  onco:acceleratedApproval "US 2023-08-14: Adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody." ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/myeloma-relapsed-refractory/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/bcma/>, <https://onco.cc/targets/cd3/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:terms <https://onco.cc/terms/crs/>, <https://onco.cc/terms/step-up-dosing/> ;
  onco:trials <https://onco.cc/trials/magnetismm-3/>, <https://onco.cc/trials/nct05623020/>, <https://onco.cc/trials/nct06152575/>, <https://onco.cc/trials/nct05020236/>, <https://onco.cc/trials/nct05317416/>, <https://onco.cc/trials/nct06988488/>, <https://onco.cc/trials/nct06106945/> .